by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Ava Inc. Warning Letter Details

Warning Letter

Ava Inc.

Recipient Title President & Chief Executive Officer, 7051 S. Adams St. Willowbrook , IL 60527-7592 United States

Issue DateApril 14, 2026

FEI Number3008736380

Violations3

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Ava Inc. FDA Warning Letter, April 14, 2026